← FDA DRUG APPROVALS

FDA ANDA · ANDA209642

MAGNESIUM SULFATE IN WATER

Sponsor: MILLA PHARMS

APPLICATION
ANDA209642
TYPE
ANDA
ORIGINAL APPROVAL
2021-11-08
LATEST ACTION
2021-11-08
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

MAGNESIUM SULFATE IN PLASTIC CONTAINERPrescription
MAGNESIUM SULFATE 4GM/50ML (80MG/ML) · INJECTABLE · INJECTION
MAGNESIUM SULFATE IN PLASTIC CONTAINERPrescription
MAGNESIUM SULFATE 2GM/50ML (40MG/ML) · INJECTABLE · INJECTION
MAGNESIUM SULFATE IN PLASTIC CONTAINERPrescription
MAGNESIUM SULFATE 4GM/100ML (40MG/ML) · INJECTABLE · INJECTION

Approval history

2021-11-08UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →